SCHEMBL5579326

SCHEMBL5579326

COc1ccc(N(C)c2ncnc3cc(I)sc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 8/20 0.50
DYRK1A Q13627 2/20 0.50
DYRK1B Q9Y463 2/20 0.50
EGFR P00533 8/20 0.46
PDGFRB P09619 4/20 0.46
KDR P35968 3/20 0.46
TUBB4A P04350 2/20 0.46
TUBB P07437 2/20 0.46
TUBA3C P0DPH7 2/20 0.46
TUBA1B P68363 2/20 0.46
TUBA4A P68366 2/20 0.46
TUBB4B P68371 2/20 0.46
TUBB3 Q13509 2/20 0.46
TUBB2A Q13885 2/20 0.46
TUBB8 Q3ZCM7 2/20 0.46
TUBA3E Q6PEY2 2/20 0.46
TUBA1A Q71U36 2/20 0.46
TUBA1C Q9BQE3 2/20 0.46
TUBB6 Q9BUF5 2/20 0.46
TUBB2B Q9BVA1 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5579136 0.80 TUBB4A (0.64) CSF1RDYRK1ADYRK1BEGFRPDGFRB
SCHEMBL5579366 0.77 NPC1 (0.49) CSF1RDYRK1ADYRK1BEGFRPDGFRB
SCHEMBL4064459 0.72 KMT2A (0.52) CSF1RDYRK1ADYRK1BEGFRPDGFRB
SCHEMBL6181267 0.72 CSF1R (0.80) CSF1REGFRPDGFRBKDRPDGFRA
SCHEMBL3112121 0.71 EGFR (0.72) CSF1REGFRPDGFRBKDRPDGFRA
Hydrochloric Acid SCHEMBL6180769 0.71 CSF1R (0.81) CSF1REGFRPDGFRBKDRPDGFRA
SCHEMBL5579199 0.71 TUBB4A (0.50) CSF1RDYRK1ADYRK1BEGFRPDGFRB
SCHEMBL5579172 0.70 TUBB3 (0.53) CSF1RDYRK1ADYRK1BEGFRPDGFRB
SCHEMBL5579182 0.70 RAB9A (0.55) CSF1RDYRK1ADYRK1BEGFRPDGFRB
SCHEMBL5472059 0.70 MEN1 (0.58) EGFRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213305-A1 N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. (US) 2007-09-13 US claimed
US-20070213305-A1 N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. (US) 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213305-A1 N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP10, CASP4, CASP3 CSF1R 2721/4885DYRK1A 4369/4885DYRK1B 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.